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Abstract
Few studies have investigated the long-term dynamics in health-related quality of life (HRQoL)
among HIV-positive persons from acute infection. From 2004, 160 women were enrolled into the
CAPRISA 002 Acute Infection study at two sites in the province of KwaZulu-Natal and
underwent 3–6 monthly HRQoL assessments using the functional assessment of HIV infection
(FAHI) instrument. Overall and 5 sub-scale FAHI scores [physical well-being (PWB), emotional
well-being (EWB), functional and global well-being (FGWB), social well-being (SWB) and
cognitive functioning (CF)] were calculated up to antiretroviral therapy (ART) initiation and
scores at enrollment were compared to the acute, early and established infection phases. Mixed-
effects regression models adjusting for behavioral and clinical factors were applied to assess
HRQoL trends and the proportion of women meeting minimally important differences was
calculated. Our analyses revealed that overall/sub-scale scores improved over time, except from
PWB and CF. A higher educational status, contraceptive use and a higher BMI were the strongest
predictors of higher overall/sub-scale FAHI scores. CD4 count and HIV viral load were strongly
associated with PWB and CF, but not overall FAHI and other sub-scales. Women newly
diagnosed with acute HIV infection face profound HRQoL challenges. While early ART delivery
may be important for PWB and CF, factors such as education, contraception provision and good
nutritional status should be promoted to maximize HRQoL in HIV positive individuals.
Keywords
Health-related quality of life; South Africa; Acute HIV infection; Functional assessment of HIV
infection
Introduction
The success of HIV treatment in preventing AIDS and death from HIV, together with a
recent sharp rise in the life-expectancy among South Africans living with HIV [1] has
refocused the emphasis on health-related quality of life (HRQoL) outcomes. Notably,
HRQoL is predictive of good adherence to life-long therapy [2, 3] and is an important
component of the well-being of individuals living with a chronic disease for which there is
currently no cure [4].
While there is no standard definition [5], the World Health Organization Quality of Life
Group generally defines quality of life [6] as “individuals’ perception of their position in the
context of the culture and value systems in which they live and in relation to their goals,
expectations, standards and concerns”. Similarly, HRQoL, quality of life related to the
health condition or the impact of illness, is often described in terms of a multi-dimensional
concept [7], incorporating the subjective assessment of individual well-being encompassing
Tomita et al. Page 2






















various aspects of an individual's life including, physical, mental and functional dimensions.
HRQoL is recognized as a dynamic phenomenon [8], changing over time depending on an
individual's circumstances.
Although international research on HRQoL in populations affected by HIV/AIDS dates back
approximately two decades [9], there has been very limited focus on this important issue in
South Africa, a country characterized by the highest burden of HIV infection globally with
5.6 million people living with HIV in 2011 [10], and an unrelenting tuberculosis co-
epidemic [11].
Despite the rapid expansion of access to antiretroviral therapy (ART) [12], the aim of
achieving universal ART access still remains a major challenge for South Africa. This is
compounded by approximately one in five people who are newly diagnosed with HIV,
refusing ART treatment, despite being eligible, according to one South Africa study [13].
Our study focused on the HRQoL of HIV-positive South African women up to ART
initiation in the KwaZulu-Natal Province, a region in South Africa that historically
encountered one of the highest HIV prevalence rates globally and considerably higher rates
in women than in men [14].
Notably, so far, most studies of HRQoL have been of cross-sectional design and have been
conducted in populations of individuals with established HIV disease, often on ART. In
contrast, this study was conducted in a cohort of acutely infected women enrolled near HIV
seroconversion and followed up repeatedly over an extended ART-free period. We were
therefore able to observe the impact of HIV infection on HRQoL over time, and to
investigate the demographic, behavioral and clinical correlates of evolving HRQoL
outcomes prior to ART initiation.
Methods
Study Population
The CAPRISA 002 Acute HIV infection study is an ongoing prospective cohort study which
started recruitment in 2004 at two sites within the province of KwaZulu-Natal, South Africa:
Durban, the largest city in KwaZulu-Natal; and Vulindlela, a rural community located 130
km northwest of Durban. Originally the study recruited a cohort of HIV-uninfected women
18 years and older at high risk of HIV infection (Phase 1) with the aim to investigate the
natural history of HIV-1 subtype C infection and to assess risk factors for disease
progression. Those women who acquired HIV were enrolled into Phase 2 (acute infection).
In addition, women who enrolled and seroconverted in other CAPRISA prevention trials
including the CAPRISA 004 microbicide trial have also entered the CAPRISA 002 study at
the Phase 2 stage. Acute HIV infection status of all study participants was established based
on plasma HIV-1 RNA testing using Amplicor or TaqMan (Roche Diagnostics, Rotkreuz,
Switzerland) prior to seroconversion or a positive HIV antibody status with a documented
HIV negative antibody test within 5 months of enrolling into the study. HIV antibody testing
was performed with two parallel rapid tests using Determine (Abbott Laboratories, Abbott
Park, IL, USA) and Capillus or Uni-Gold (Trinity Biotech, Jamestown, NY, USA)
depending on the study cohort. All discordant rapid HIV antibody tests were confirmed with
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Enzygnost EIA using the BEP 2000 (Siemens, Marburg, Germany). The moment of HIV
infection was estimated as 14 days before a positive RNA PCR test (if RNA positive and
antibody negative) or the midpoint between the last antibody negative and first antibody
positive result. Women who met the inclusion criteria were provided with a complete
description of the CAPRISA 002 study, and written informed consent was obtained for
participation and specimen storage. Consent forms and study information for participants
were available in English and isiZulu, the local language in the province. The study
methodology, including recruitment methods and eligibility criteria for the CAPRISA 002
and 004 studies, was previously described in detail [15, 16].
Study participants had their initial acute infection baseline assessment immediately after
HIV diagnosis. Participants were then followed-up in three phases defined by their distance
to the time of infection; acute infection (Phase II ≤3 months, but excluding the baseline
assessment), early infection (Phase III >3–12 months) and established infection (Phase IV
>12 months) and were censored at ART initiation. Clinical management of participants and
ART initiation was conducted according to the South African Adult HIV Treatment
Guidelines [17] with women starting treatment at a CD4 count of 200 cells/μl until 2009 and
at 350 cells/μl since then. Participant follow-up in the CAPRISA 002 Acute Infection study
continues and additional data is currently being collected for women on ART (Phase V).
At the time of this study, 142 of 160 study participants had entered Phase IV with a median
HIV-positive follow-up of 46.1 months (interquartile range 32.2–58.5) since baseline
assessment up to ART initiation. The median number of assessments per study participant
was 27 visits (range 2–45). Participants were reimbursed for their time and travel expense at
each assessment. All study participants received HIV post-test counseling, education on
onward transmission and condom provision, as well as sexually transmitted infection risk
reduction counseling and referral for treatment if required. All participants requiring clinical
care received it either at the CAPRISA clinical research sites in Durban or Vulindlela, or
were referred to a specialist facility. The Biomedical Research Ethics Committee of the
University of KwaZulu-Natal approved the study.
Measures
Once enrolled into the study, face-to-face interviews were conducted in either English or
isiZulu by trained research clinicians, nurses or counselors, and study data were obtained at
various stages depending on the types of measures being assessed. HRQoL, the primary
outcome of this study, was assessed via participant self-report at baseline, month 3 and bi-
annually thereafter by trained clinical research interviewers using the functional assessment
of HIV infection (FAHI) instrument [18, 19]. Specifically developed to capture perspectives
on HRQoL of individuals living with HIV/AIDS, FAHI is psychometrically reliable and a
validated instrument containing 44 items. The instrument, available both in English and
isiZulu, has been used in a previous study involving people living with HIV infection in
KwaZulu-Natal, South Africa [20]. Multiple iterations of translation/back translation and a
linguistic validation on the quality of the translation and cultural appropriateness were
conducted by CAPRISA and the team which created FAHI. The instrument captures five
subscales of HRQoL: physical well-being (PWB) (ten items), emotional well-being (EWB)
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(ten items), functional and global well-being (FGWB) (13 items), social well-being (SWB)
(eight items), and cognitive functioning (CF) (three items). Each item is rated on a 5-point
ordinal scale of 0 (not at all) to 4 (very much). An overall HRQoL score (44 items) was
calculated by summing the subscale scores, and ranged from 0 to 176, with a higher score
indicating a better HRQoL. The Cronbach alpha, internal consistency coefficient of the
overall FAHI, was 0.86. Consistency coefficients for the PWB, EWB, FGWB, SWB, and
CF sub-scales were 0.88, 0.83, 0.85, 0.72 and 0.65, respectively.
Self-care behavior encompasses important aspects of HRQoL [21].. HIV knowledge and risk
behavior assessments, conducted at baseline, month 3 and bi-annually thereafter, captured
the recent sexual history, in particular, the frequency of various sexual acts (peno-vaginal,
anal, oral, and sex acts under the influence of alcohol or other substances) and the number of
casual partners, irrespective of marital status. For each type of sexual act, risky sexual
behavior was categorized as no/low risk, if the study participant responded having no sex or
sex with a condom being used every time, or high risk, if the study participant responded
having sex without the use of a condom every time based on self-report. Risk predictors
related to the casual partners, were coded as no/low risk, if the study participant did not
report having any casual partners, or high risk if the study participant responded having at
least one casual partner. Information pertaining to contraceptive use and knowledge about
HIV transmission were only obtained at baseline.
During the routine clinical examinations at every study visit, measurements for body mass
index (BMI) and specimens for laboratory assessment (including CD4 and viral load) were
obtained. The BMI was categorized into three groups: underweight (<18.5 kg/m2), normal
(18.5–24.9 kg/m2) and overweight/obese (≥25 kg/m2).
Data Analyses
Descriptive statistics were used to summarize baseline characteristics and the various FAHI
scores (overall score, PWB, EWB, FGWB, SWB and CF) at baseline, acute infection, early
infection and established infection. Paired comparisons between baseline scores and the
other phases of HIV infection were conducted using Wilcoxon signed-rank tests. Tobit
regression was used to determine the covariates associated with baseline FAHI scores.
Linear mixed effects regression models were fitted to longitudinal FAHI scores to assess
trends over time and factors associated with change from baseline, adjusting for
demographic, HIV knowledge/behavioral risk, clinical and biological factors.
The proportion of women who met minimally important differences (MID) above the
threshold in Phase IV was calculated. For this analysis we focused on two distribution-based
methods to derive MID; the first being half the standard deviation of the baseline score [22]
(SD method), and secondly the standard error of measurement (SEM method), which is a
deviation of the baseline score multiplied by the square root of 1 minus the reliability
coefficient [23]. Figures were used to illustrate the overall and sub-scale HRQoL score
trends over time. The trend in the observed score was fitted using the fractional polynomial
prediction method. All analyses were conducted using STATA version 12 (StataCorp,
College Station, TX, USA) and SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
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Baseline Characteristics of the Cohort
The baseline characteristics assessment of the 160 study participants is presented in Table 1.
The median estimated time from HIV infection to the initial (baseline) assessment was 42
days (IQR 28-62). All participants were women, with a median age of 24 years (range 18–
59). Almost all (99.4 %) were black South African, 70.6 % (113) reported having completed
grades 11 or 12 of schooling, and 75.0 % (120) had a stable partner or were married. Twenty
women (12.5 %) reported to be engaging in sex work and half (50 %) had children who
were financially dependent on them. The mean CD4 count at enrollment into the study was
566 cells/mm3 (229–1358) and median log viral load was 4.5 copies/ml (2.6–6.3).
Quality of Life Dynamics Over Time
The overall FAHI and five sub-scale scores [PWB, EWB, FGWB, SWB and CF] were
calculated for each phase as presented in Table 2. The overall HRQoL score was lowest at
baseline. EWB, FGWB, SWB and the overall HRQoL scores increased from HIV diagnosis
(baseline) through acute and early infection (Phases II and III) and established infection
(Phase IV) for all comparisons with baseline. PWB scores remained stable throughout all
phases, while CF scores initially increased up until the early infection phase and then
declined during established infection. Figure 1 illustrates the overall and five sub-scale
FAHI scores over time. Based on visual assessment, the overall FAHI, EWB, FGWB, and
SWB scores showed a marked improvement over time, particularly within the first year of
follow-up, while a slowly declining trend was seen for PWB and CF.
Baseline Predictors of Quality of Life
Results of the baseline regression analyses using the Tobit model indicated that lower
educational status [overall (β = –18.8, p = 0.02), PWB (β = –11.1, p = 0.01)] and ages 21–24
compared to 18–20 years [PWB (β = –6.6, p = 0.03)] were negatively associated with
certain FAHI domains. In contrast, the use of a contraceptive [overall (β = 8.6, p = 0.04),
EWB (β = 4.4, p = 0.03)], a married status [overall (β = 24.0, p = 0.01), PWB (β = 7.8, p <
0.05), EWB (β = 9.6, p = 0.01)], and higher HIV-1 viral load (β = 1.8, p = 0.01) and CD4
counts (β = 0.01, p = 0.01) (SWB) were positively associated with certain FAHI domains.
Predictors of Quality of Life Dynamics
Assessment of the trends in the overall and sub-scale HRQoL scores using mixed-effects
regression models and adjusting for demographic, HIV behavioral risk and clinical/
biological factors (full model), are presented in Table 3. The overall FAHI, EWB, FGWB,
and SWB improved over time. PWB and CF declined over time, but this did not reach
statistical significance. In the adjusted analysis several covariates were strongly associated
with FAHI outcomes. Among these were a higher educational status, which was associated
with a higher overall and all sub-scale FAHI scores except from SWB, contraceptive use
(associated with a higher overall FAHI, FGWB, and SWB scores) and a higher BMI
(associated with higher overall FAHI, PWB and FGWB scores). While a higher CD4 count
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was associated with a better PWB and CF, there was no association with HIV viral load. A
stable partnership was associated with better FGWB and CF scores.
A preliminary analysis using unadjusted regression models indicated that sex worker status
was associated with a lower overall FAHI score, a higher viral load was associated with a
lower PWB, FGWB and CF, and knowledge of how HIV transmits was associated with a
higher EWB score.
Meaningful Improvement in Quality of Life
Table 4 shows the proportion of women who achieved a potentially meaningful difference in
their FAHI scores. There was no substantial difference between the MID SD and SEM
methods. Over 60 % of study participants experienced meaningful improvements in their
overall HRQoL score. Half of the study participants showed improvements in EWB,
approximately 70 % in SWB and one-third showed improvements in FGWB. In contrast,
only a small proportion reached a meaningful threshold in PWB and CF.
Discussion
Our study, utilizing rare data from a prospective cohort study of subtype-C infected women
with an extensive follow-up period, indicates that overall HRQoL, and more specifically
EWB, FGWB and SWB improved over time from acute HIV infection up to ART initiation.
No improvements were found in the PWB and CF of participants. With the caveat that post-
HIV support and services including counseling, HIV education and medical treatment were
available during the course of the study, women diagnosed with acute HIV infection showed
remarkable resilience in the EWB, FGWB and SWB aspects of their lives.
Our findings suggest that women newly diagnosed with acute HIV infection face profound
HRQoL challenges, immediately after HIV diagnosis. Compared to other studies which
utilized FAHI [19, 24, 25], the baseline levels of HRQoL were relatively high in our study.
This may have been explained by the fact that baseline assessments were conducted during
the acute infection phase and participants had already been receiving care in prevention
studies while HIV uninfected. It is plausible that certain domains, such as PWB, could have
been rated higher during acute and early infection when there were fewer severe symptoms
compared to during the later stages of the HIV infection course. Nonetheless, the time
immediately after diagnosis is one of uncertainty for women living with acute HIV
infection, as evidenced by the lowest overall HRQoL scores measured at that time of the
study. Fear of rejection and social discrimination associated with HIV disclosure may be
stigmatizing [26], and negatively influencing quality of EWB and social relationships. Time
of HIV diagnosis can often be marked by maladaptive coping strategies to the stressful
event. Affective responses during this period can range from fear of death [27] and
ostracism [28], to complete denial [29] of the disease and intense anger towards oneself and
others. Behavioral responses, though not all negative, can range anywhere from an
‘autopilot’ reaction to highly self-destructive behavior involving substance use and acting
out sexually [30]. This in turn can have negative repercussions, for example, on PWB, and
can hamper recovery.
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Our study highlights the potential challenge for improvements in EWB and SWB. Biological
and clinical predictors (CD4 count, viral load and BMI) were strongly correlated, but limited
to the physical or functional aspects of HRQoL. In fact, in the bivariate analysis during
follow-up assessments and Tobit regression model for baseline analyses, higher CD4 count
and lower viral load were associated with a lower SWB. This complex relationship
potentially highlights the social turmoil experienced by recently diagnosed women, despite
relatively good immune status. Role theories highlight the tension between personal and
social expectations [31] and its influence on SWB [32], perceived quality in functioning and
circumstance in relations to community and society. This may also partially help explain
unmet life expectations (and thus lower HRQoL scores) among those with relatively good
immune status.
Our study cohort exhibited signs of a decline in PWB and CF over time up to ART
initiation. Such finding was somewhat expected based on past studies [33, 34], but whether
this could indicate the onset of an HIV-associated neurocognitive decline [35, 36] due to a
prolonged exposure to HIV remains to be seen. Nevertheless, the study provides some
additional evidence to justify, perhaps, timely provision of ART, to reverse the detrimental
effects of HIV. However, maximizing HRQoL and improving well-being aspects of quality
of life among this population, means looking beyond biological markers and the provision of
ART alone as being sufficient for an intervention. Women living with HIV compared to
HIV-positive men often face different types of life challenges and responsibilities, including
lower education [37], transportation challenges to accessing HIV care [38], and having
children [39]. Power imbalance in negotiating condom use to partners in KwaZulu-Natal,
South Africa [40] is also recognized as one of the factors in contributing to the transmission
of HIV/AIDS in this region. Gender difference plays a significant role in quality of life [41–
43] in the lives of women living with HIV, and more than any other covariates, educational
attainment was strongly associated with almost all aspects of HRQoL in our study. As
shown by the low baseline HRQoL scores, particularly among young women (ages 21–24),
raising educational levels of women fosters HIV knowledge and may encourage protective
behaviors, such as self-assertion with regards to contraceptive use and negotiation for safer
sex. For these reasons, our study not only advocates for the importance of broader policy
need for empowering women through education, but also improving access to evidence/
community-based behavioral interventions tailored to the needs specifically of women living
with HIV, similar to that of Women Involved in Life Learning from Other Women
(WiLLOW) model [44], which teaches coping skills and maintains a social support network
relevant in the South African context.
The major strength of this study is the assessment of HRQoL longitudinally up to 90 months
post-infection with retention rates of 95 %. While HRQoL studies related to HIV are not
new, our study provides a rare illustration of the wide-ranging trajectories and
developmental processes of women living with HIV in relation to HRQoL, beginning from
the acute infection stage.
There were a number of limitations to our study. Firstly, all study participants were entitled
to post-HIV care including counseling, health education and provision of medical care. The
proportion of study participants who utilized these services or how much these services may
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have affected the HRQoL outcomes is unknown. Secondly, full-scale culturally adapted
FAHI instruments were not available, which may have affected the reliability of certain
domains, for example, CF assessment. While all instruments on the CAPRISA 002 were
pre-tested with participant feedback, future studies should adhere to the recommended
cultural adaptation guidelines [45, 46]. Lastly, our study included only pre-selected domains
using FAHI, which is only a first step towards better understanding the priorities and
domains unique to each individual, and how they relate to individual goals and expectations
of living with HIV. To this end, further studies based on qualitative methods may be
warranted to accurately identify pertinent domains and their relative importance [47].
Conclusions
Women newly diagnosed with acute HIV infection face profound challenges, requiring an
evidence-based approach to maximizing HRQoL. Effective provision of ART will continue
to be an essential intervention for the management of HIV-infected individuals in certain
aspects of HRQoL, but it alone is insufficient. While individual-level, clinical-, and
behavior-changing interventions are critical, broader structural inequities which impede
access and empowerment of women through education also need to be addressed. Our study
provides a rare illustration of extensive life trajectories of women living with HIV over time
up to ART initiation, beginning from the acute infection stage. Even as newly diagnosed
women faced multifaceted challenges, their EWB, FGWB and SWB aspects of HRQoL
improved with time, showing resilience in the aftermath of being diagnosed with a life-
threatening disease.
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Table 1
Baseline characteristics of South African women in the CAPRISA 002 study (N = 160)
Variable Category n %





Race Black 159 99.4
Coloured 1 0.6
Marital status Married/stable partner 120 75.0
Many partners 11 6.9
No partner—single 29 18.1
Presence of casual partners Yes 25 15.8
Highest completed education Less than high school <8th grade 7 4.4
High school up to 10th grade 40 25.0
At least grade 11/12 113 70.6
Any financially child dependents Yes 80 50.0
Contraception use Yes 127 79.4
Knowledge of HIV Yes 141 88.1
Sex work Yes 20 12.5




a Cells per mm3 Mean = 566.2 SD = 220.7
Log viral load
a Copies/mL Mean = 4.3 SD = 0.9
a
3-month post infection
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Table 4
Number of participants meeting meaningful difference (MD) improvement (n = 140)
Domains Mean score difference between baseline enrollment and
established infection stage
SD method SEM method
MD No. meeting threshold MD No. meeting threshold
Overall 17.3 9.7 89 (64 %) 7.3 102 (73 %)
PWB 0.3 2.2 17 (12 %) 1.5 27 (19 %)
EWB 5.9 4.2 73 (52 %) 3.5 80 (57 %)
FGWB 3.4 3.8 38 (27 %) 2.9 50 (36 %)
SWB 7.6 3.6 96 (69 %) 3.8 95 (68 %)
CF 0.04 1.1 22 (16 %) 1.3 21 (15 %)
Overall total quality of life score (0–176), PWB physical well-being (0–40), EWB emotional well-being (0–40), FGWB functional and global well-
being (0–52), SWB social well-being (0–32), CF cognitive functioning (0–12)
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